MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, DAWN made $39,795,000 in revenue. -$19,726,000 in net income. Net profit margin of -49.57%.

Income Overview

Revenue
$39,795,000
Net Income
-$19,726,000
Net Profit Margin
-49.57%
EPS
-$0.19
Unit: Dollar
Revenue Breakdown
    • Product
    • License

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenues
39,795,000 33,908,000 30,761,000 12,466,666.667
Cost of product and license revenue
4,480,000 3,765,000 --
Research and development
31,419,000 36,149,000 39,619,000 64,713,000
Selling, general and administrative
28,147,000 28,968,000 29,325,000 28,826,000
Cost of product revenue
--2,884,000 1,229,666.667
Total cost and operating expenses
64,046,000 68,882,000 71,828,000 94,768,666.667
Loss from operations
-24,251,000 -34,974,000 -41,067,000 -82,302,000
Gain from sale of priority review voucher
0 0 -36,000,000
Investment income, net
4,559,000 4,671,000 5,094,000 4,793,000
Other expense, net
-34,000 -19,000 -23,000 6,666.667
Total non-operating income, net
4,525,000 4,652,000 5,071,000 40,799,666.667
Loss before income taxes
19,726,000 30,322,000 35,996,000 41,502,333.333
Income tax expense
0 0 -2,675,333.333
Net loss
-19,726,000 -30,322,000 -35,996,000 -44,177,666.667
Earnings per share, basic
-0.19 -0.29 -0.35 -0.467
Earnings per share, diluted
-0.19 -0.29 -0.35 -0.467
Weighted average number of shares outstanding, basic
103,381,315 103,069,154 102,710,382 -1,129,642.667
Weighted average number of shares outstanding, diluted
103,381,315 103,069,154 102,710,382 -1,234,521.333
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$19,726,000 Investment income, net$4,559,000 Loss before incometaxes$19,726,000 Total non-operatingincome, net$4,525,000 License$1,273,000 Product$38,522,000 Other expense, net-$34,000 Loss from operations-$24,251,000 Total revenues$39,795,000 Total cost andoperating expenses$64,046,000 Selling, general andadministrative$28,147,000 Research and development$31,419,000 Cost of product andlicense revenue$4,480,000

Day One Biopharmaceuticals, Inc. (DAWN)

Day One Biopharmaceuticals, Inc. (DAWN)